University of California, Irvine Medical Center
Orange, California, 92868, United States
NCT Number: NCT00581412
This study is to determine whether the use of a composite biologic/synthetic graft during abdominal sacrocolpopexy leads to a lower rate of erosion while maintaining durability.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Orange, California, 92868, United States
This study will examine the erosion rate of a composite graft that is being used during abdominal sacrocolpopexy. The composite graft is composed of a dual layer of biological and syntheric material. Biological grafts have the advantage of significantly reducing erosion rates, but the longevity of biologic graft is uncertain. On the other hand, synthetic grafts have the advantage in that they are durable, but have higher erosion rates through the vagina and require re-operation in a small percentage of patients. This study will look at whether or not the use of a composite greaft carries the advantages of both types of materials and leads to decreased rates of erosion while maintaining longevity. The cost effectiveness of this new type of graft will also be reviewed since the disavantage of utilizing both the synthetic and biologic graft is that it will increase the cost.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: To the point of graft erosion after abdominal sacrocolpopexy
Time frame: To the point of graft erosion after abdominal sacrocolpopexy
Looking for future studies?
Notify MeUniversity of California, Irvine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06245577
Digestive System Diseases, Gastrointestinal Diseases
Cologne, North Rhine-Westphalia, Germany
View Trial DetailsNCT03244397
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Alcalà de Henares, Madrid, Spain
View Trial DetailsNCT03973281
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT07746739
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Padang, West Sumatera, Indonesia
View Trial Details